ZEB2 and neoplasm: ZEB2 expression is associated with a poor oncological prognosis and distant recurrence; hence, incorporating ZEB2 expression status into the tumor–node–metastasis (TNM) staging system facilitates the process of identifying patients who are at high risk of recurrence [95].